{"transactions":[{"id":745410,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-09T23:35:33.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":2938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2938,"derivative":{"exercise_price":237,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":2938},"source":{"system":"sec-edgar","filing":"0002001011-26-000096","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000096/edgardoc.xml","form_type":"4"}},{"id":745409,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T23:35:33.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":8930,"source":{"system":"sec-edgar","filing":"0002001011-26-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000096/edgardoc.xml","form_type":"4"}},{"id":1002977,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-12T21:45:03.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":false,"shares":3015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Option was previously reported as a Grant of 3,452 shares, which vested in full on August 18, 2020, at an exercise price of $126.2600 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":73.57,"expiration_date":"2027-08-18","underlying":"Common Stock","underlying_shares":3015},"source":{"system":"sec-edgar","filing":"0002001011-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000098/edgardoc.xml","form_type":"4"}},{"id":1002976,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-12T21:45:03.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":false,"shares":3556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option was previously reported as a Grant of 4,071 shares, which vested in full on June 06, 2020, at an exercise price of $113.5900 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":66.19,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":3556},"source":{"system":"sec-edgar","filing":"0002001011-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000098/edgardoc.xml","form_type":"4"}},{"id":1002975,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:45:03.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":3015,"price":205.45,"value":619431.75,"ownership":{"direct":true},"balance_after":8094,"source":{"system":"sec-edgar","filing":"0002001011-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000098/edgardoc.xml","form_type":"4"}},{"id":1002974,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:45:03.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":true,"shares":3015,"price":73.57,"value":221813.55,"ownership":{"direct":true},"balance_after":11109,"source":{"system":"sec-edgar","filing":"0002001011-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000098/edgardoc.xml","form_type":"4"}},{"id":1002973,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:45:03.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":3556,"price":205.45,"value":730580.2,"ownership":{"direct":true},"balance_after":8094,"source":{"system":"sec-edgar","filing":"0002001011-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000098/edgardoc.xml","form_type":"4"}},{"id":1002972,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:45:03.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":true,"shares":3556,"price":66.19,"value":235371.64,"ownership":{"direct":true},"balance_after":11650,"source":{"system":"sec-edgar","filing":"0002001011-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000098/edgardoc.xml","form_type":"4"}},{"id":1116965,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-10T23:39:41.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":5783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5783,"derivative":{"exercise_price":105.99,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":5783},"source":{"system":"sec-edgar","filing":"0002001011-25-000046","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000046/edgardoc.xml","form_type":"4"}},{"id":1116964,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-10T23:39:41.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":1209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":8094,"source":{"system":"sec-edgar","filing":"0002001011-25-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000046/edgardoc.xml","form_type":"4"}},{"id":1476308,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-19T01:26:16.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5444,"derivative":{"exercise_price":80.06,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5444},"source":{"system":"sec-edgar","filing":"0002001011-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000056/edgardoc.xml","form_type":"4"}},{"id":1476307,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:26:16.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":1252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":6885,"source":{"system":"sec-edgar","filing":"0002001011-24-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000056/edgardoc.xml","form_type":"4"}},{"id":1512764,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-18T00:00:48.000Z","date":"2024-05-09","kind":"sale","planned":false,"acquired":false,"shares":934,"price":83.2049,"value":77713.3766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.1100 to $83.2650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5633,"source":{"system":"sec-edgar","filing":"0002001011-24-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000054/edgardoc.xml","form_type":"4"}},{"id":1857838,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-13T22:55:56.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":5461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5461,"derivative":{"exercise_price":73.76,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":5461},"source":{"system":"sec-edgar","filing":"0000886163-23-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000043/edgardoc.xml","form_type":"4"}},{"id":1857837,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T22:55:56.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":1142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":6567,"source":{"system":"sec-edgar","filing":"0000886163-23-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000043/edgardoc.xml","form_type":"4"}},{"id":2076334,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-27T23:31:22.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":3050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023."}],"balance_after":3050,"derivative":{"exercise_price":67.03,"expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":3050},"source":{"system":"sec-edgar","filing":"0000899243-22-039409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322039409/doc4.xml","form_type":"4"}},{"id":2234862,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-13T22:46:20.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4340,"derivative":{"exercise_price":79.29,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4340},"source":{"system":"sec-edgar","filing":"0000886163-22-000081","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000081/edgardoc.xml","form_type":"4"}},{"id":2234861,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:46:20.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":1004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4706,"source":{"system":"sec-edgar","filing":"0000886163-22-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000081/edgardoc.xml","form_type":"4"}},{"id":2680008,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-08T01:24:58.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":3269,"derivative":{"exercise_price":115.39,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0000886163-21-000091","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000091/edgardoc.xml","form_type":"4"}},{"id":2680007,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T01:24:58.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":3702,"source":{"system":"sec-edgar","filing":"0000886163-21-000091","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000091/edgardoc.xml","form_type":"4"}},{"id":3112441,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-12T22:34:21.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":2468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2468,"derivative":{"exercise_price":117.58,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":2468},"source":{"system":"sec-edgar","filing":"0000886163-20-000077","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000077/edgardoc.xml","form_type":"4"}},{"id":3112440,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T22:34:21.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":3072,"source":{"system":"sec-edgar","filing":"0000886163-20-000077","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000077/edgardoc.xml","form_type":"4"}},{"id":3497942,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-07T22:52:34.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4071,"derivative":{"exercise_price":113.59,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":4071},"source":{"system":"sec-edgar","filing":"0000886163-19-000106","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000106/edgardoc.xml","form_type":"4"}},{"id":3497941,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T22:52:34.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2241,"source":{"system":"sec-edgar","filing":"0000886163-19-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000106/edgardoc.xml","form_type":"4"}},{"id":3876965,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-03T22:43:53.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":195.91,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000886163-18-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000098/edgardoc.xml","form_type":"4/A","original_submission_date":"2018-06-21"}},{"id":3886510,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-21T20:45:36.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":76.77,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000899243-18-017608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017608/doc4.xml","form_type":"4"}},{"id":3886509,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T20:45:36.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":1406,"source":{"system":"sec-edgar","filing":"0000899243-18-017608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017608/doc4.xml","form_type":"4"}},{"id":4227937,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-22T16:50:23.000Z","date":"2017-08-18","kind":"grant","acquired":true,"shares":3452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-Qualified Stock Option (right to buy)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 3 successive equal annual installments upon completion of each calendar year of service beginning on the grant date."}],"balance_after":3452,"derivative":{"exercise_price":126.26,"exercise_date":"2018-08-18","expiration_date":"2027-08-18","underlying":"Common Stock","underlying_shares":3452},"source":{"system":"sec-edgar","filing":"0000886163-17-000106","document":"wf-form4_150342057116504.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000106/wf-form4_150342057116504.xml","form_type":"4"}},{"id":4227936,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40265,"kind":"person","name":"Gray Nancy Ryan","position":1,"cik":"0001714949","reported_name":"Gray Nancy Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-22T16:50:23.000Z","date":"2017-08-18","kind":"grant","acquired":true,"shares":913,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":913,"source":{"system":"sec-edgar","filing":"0000886163-17-000106","document":"wf-form4_150342057116504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000106/wf-form4_150342057116504.xml","form_type":"4"}}]}